Machine Learning Algorithms to Fight the COVID-19 Pandemic

Monalisha Pattnaik; Aryan Pattnaik; Alipsa Pattnaik

doi:10.1101/2022.12.31.22284091

Abstract

The ongoing novel COVID-19 global pandemic is one of the health emergencies in 21^st century after hundred years of Spanish flu that affected almost all the countries in the world. The objective of this study is to generate STM and LTM real-time out of sample forecasts of the future COVID-19 confirmed and death cases respectively for the top five mostly affected countries in the world namely USA, India, Brazil, Russia and UK. As of January 17, 2021, it has caused a pandemic outbreak with more than 94.5 million confirmed cases and more than 2 million reported deaths worldwide. Due to extreme robust behaviour in the univariate time series data, forecasting of both COVID-19 confirmed and death cases has become the exigent task for the government officials, healthcare workers, economists, corporate leaders, government, decision makers, public-policy makers, and scientific experts to allocate health resources. To solve this problem different hybrid approaches are applied which eliminate both linear and non-linear errors of the time series datasets and the predictions of for these countries will be practical to act as forewarning for all.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes